Abstract:
Novel pharmaceutical compositions are disclosed. The compositions comprise an aryl substituted alanine and a substituted phenyl hydrazino propionic acid. The compositions are useful for treating hypertension.
Abstract:
Novel pharmaceutical compositions are disclosed. The compositions comprise an aryl substituted alanine and a substituted phenyl hydrazino propionic acid. The compositions are useful for treating hypertension.
Abstract:
Novel pharmaceutical compositions comprising hydrazino-phenylpropionic acid decarboxylase inhibitors and certain benzimidazole and benzoxazole alanines are disclosed. The compositions have enhanced hypotensive activity.
Abstract:
Novel pharmaceutical compositions are disclosed. The compositions comprise an aryl substituted alanine and a substituted phenyl hydrazino propionic acid. The compositions are useful for treating hypertension.
Abstract:
Novel pharmaceutical compositions comprising hydrazino-phenylpropionic acid decarboxylase inhibitors and certain benzimidazole and benzoxazole alanines are disclosed. The compositions have enhanced hypotensive activity.
Abstract:
The present invention relates to a novel and useful method of treatment and a composition which is used to treat hypertension. More particularly, it relates to the administration of a composition containing (A) L-.alpha.-hydrazino-.alpha.-loweralkyl-3,4-dihydroxyphenyl propionic acid or .alpha.-hydrazino-3,4-dihydroxyphenyl propionic acid or a pharmaceutically acceptable non-toxic salt of either in combination with (B) a specific class of esters of .alpha.-methyl-3,4-dihydroxyphenylalaninate or a salt thereof.
Abstract:
A method of treating hypertension by administration, to hypertensive patients, of an anti-hypertensive amount of certain tripeptides, is disclosed.
Abstract:
Compounds of the formula ##STR1## possess antihypertensive activity. Also provided are methods for the preparation of the compounds as well as pharmaceutical formulations and methods for their use as antihypertensive agents.